Magnetismo y Óptica Aplicados
FQM335
AstraZeneca (United Kingdom)
Cambridge, Reino UnidoAstraZeneca (United Kingdom)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2022
-
Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial
The Lancet Respiratory Medicine, Vol. 10, Núm. 10, pp. 985-996